Bioamber Inc (BIOAQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2014 | 12-2013 | 09-2013 | 06-2013 | 03-2013 | |
| Sales | 351 | 440 | 867 | 1,028 | 331 |
| Cost of Goods | 280 | 424 | 655 | 1,411 | 199 |
| Gross Profit | 71 | 16 | 211 | -383 | 132 |
| Operating Expenses | 7,852 | 8,249 | 6,714 | 17,706 | 10,176 |
| Operating Income | -7,501 | -7,809 | -5,848 | -17,678 | -9,846 |
| Other Income | -12,426 | 5,724 | -3,097 | 10,500 | 230 |
| Pre-tax Income | -19,927 | -2,085 | -8,945 | -7,178 | -9,616 |
| Income Tax | 25 | 34 | 22 | 47 | N/A |
| Net Income Continuous | -19,952 | -2,119 | -8,967 | -7,225 | -9,616 |
| Minority Interests | -41 | -157 | -133 | -168 | -116 |
| Net Income | $-19,911 | $-1,962 | $-8,834 | $-7,057 | $-9,500 |
| EPS Basic Total Ops | -1.07 | 0.12 | -0.48 | -0.47 | -0.92 |
| EPS Basic Continuous Ops | -1.08 | 0.10 | -0.49 | -0.48 | -0.93 |
| EPS Diluted Total Ops | -1.07 | 0.12 | -0.48 | -0.47 | -0.92 |
| EPS Diluted Continuous Ops | -1.08 | 0.10 | -0.49 | -0.48 | -0.93 |
| EBITDA(a) | $-7,369 | $-7,894 | $-5,616 | $-17,022 | $-9,243 |